Update news pharma

Vietnamese pharmaceutical giants rushed to new business lines in 2020 to create new motivation for growth amid the ongoing pandemic complications, with some changes bringing about better results.

VN pharma landscape set for shake-up

Facing significant expansion from multinational corporations, Vietnamese drug giants took a hit in 2019 despite new strategies, signalling an uninspiring outlook for future growth.  

Pharma giants seek to cash in on local market potential

While several sectors are being hit by the coronavirus outbreak, the pharmaceutical and healthcare industry is taking an advantage, with numerous expansion strategies among players being placed in the gun barrel.

Foreign direct investment and mature M&A boost investor confidence

The past two years have seen capital flows into Vietnam continue to steadily increase, as well as some of the country’s biggest mergers and acquisitions deals to date. 

Vietnam looks for more FDI into pharmacy sector

The Ministry of Health (MOH) estimates that Vietnam has to remit $2 billion abroad to import foreign drugs but could retain more money in-country if it could attract FDI into the pharmaceutical industry.

Import medicine dislodges locally-made products

 VietNamNet Bridge – Expensive imported medicine has been dominating the Vietnamese market, a poor country with the average income per capita at $1,000 a year.